Gene modification therapies: views of parents of people with Down syndrome

Marsha Michie, Megan Allyse

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: In considering gene modification technologies, the priorities of patient communities must be a central consideration. The purpose of this study is to assess views of families with Down syndrome (DS) regarding potential genome-based interventions. Methods: We constructed an anonymous online survey for family members of people with DS. Participants were asked to agree or disagree with scenarios describing hypothetical interventions to silence or significantly alter the physical and cognitive effects of a trisomy 21, and also with scenarios depicting currently available physical interventions. Results: All 532 respondents were parents of people with DS. For each of the five scenarios, over half said they would approve the intervention or would advise their children with DS to do so. Responses to hypothetical prenatal and pediatric cognitive interventions were significantly affected by participants’ assessments of the impact of DS on their children’s and their families’ lives, while physical and adult cognitive scenarios were not. Conclusion: Future interventions to address genetic conditions will impact patient communities and cannot succeed without their input and support. While many parents of people with DS indicated approval for hypothetical genetic therapies, these results indicate a need for continuing dialogue about benefits and drawbacks of gene modification technologies.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalGenetics in Medicine
DOIs
StateAccepted/In press - Jun 21 2018

Fingerprint

Down Syndrome
Genetic Therapy
Parents
Technology
Genes
Genome
Pediatrics

Keywords

  • CRISPR
  • Down syndrome
  • Gene editing
  • Gene silencing
  • Intellectual disability

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Gene modification therapies : views of parents of people with Down syndrome. / Michie, Marsha; Allyse, Megan.

In: Genetics in Medicine, 21.06.2018, p. 1-6.

Research output: Contribution to journalArticle

@article{d15eb3c817354f738bef394f8d303bd3,
title = "Gene modification therapies: views of parents of people with Down syndrome",
abstract = "Purpose: In considering gene modification technologies, the priorities of patient communities must be a central consideration. The purpose of this study is to assess views of families with Down syndrome (DS) regarding potential genome-based interventions. Methods: We constructed an anonymous online survey for family members of people with DS. Participants were asked to agree or disagree with scenarios describing hypothetical interventions to silence or significantly alter the physical and cognitive effects of a trisomy 21, and also with scenarios depicting currently available physical interventions. Results: All 532 respondents were parents of people with DS. For each of the five scenarios, over half said they would approve the intervention or would advise their children with DS to do so. Responses to hypothetical prenatal and pediatric cognitive interventions were significantly affected by participants’ assessments of the impact of DS on their children’s and their families’ lives, while physical and adult cognitive scenarios were not. Conclusion: Future interventions to address genetic conditions will impact patient communities and cannot succeed without their input and support. While many parents of people with DS indicated approval for hypothetical genetic therapies, these results indicate a need for continuing dialogue about benefits and drawbacks of gene modification technologies.",
keywords = "CRISPR, Down syndrome, Gene editing, Gene silencing, Intellectual disability",
author = "Marsha Michie and Megan Allyse",
year = "2018",
month = "6",
day = "21",
doi = "10.1038/s41436-018-0077-6",
language = "English (US)",
pages = "1--6",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Gene modification therapies

T2 - views of parents of people with Down syndrome

AU - Michie, Marsha

AU - Allyse, Megan

PY - 2018/6/21

Y1 - 2018/6/21

N2 - Purpose: In considering gene modification technologies, the priorities of patient communities must be a central consideration. The purpose of this study is to assess views of families with Down syndrome (DS) regarding potential genome-based interventions. Methods: We constructed an anonymous online survey for family members of people with DS. Participants were asked to agree or disagree with scenarios describing hypothetical interventions to silence or significantly alter the physical and cognitive effects of a trisomy 21, and also with scenarios depicting currently available physical interventions. Results: All 532 respondents were parents of people with DS. For each of the five scenarios, over half said they would approve the intervention or would advise their children with DS to do so. Responses to hypothetical prenatal and pediatric cognitive interventions were significantly affected by participants’ assessments of the impact of DS on their children’s and their families’ lives, while physical and adult cognitive scenarios were not. Conclusion: Future interventions to address genetic conditions will impact patient communities and cannot succeed without their input and support. While many parents of people with DS indicated approval for hypothetical genetic therapies, these results indicate a need for continuing dialogue about benefits and drawbacks of gene modification technologies.

AB - Purpose: In considering gene modification technologies, the priorities of patient communities must be a central consideration. The purpose of this study is to assess views of families with Down syndrome (DS) regarding potential genome-based interventions. Methods: We constructed an anonymous online survey for family members of people with DS. Participants were asked to agree or disagree with scenarios describing hypothetical interventions to silence or significantly alter the physical and cognitive effects of a trisomy 21, and also with scenarios depicting currently available physical interventions. Results: All 532 respondents were parents of people with DS. For each of the five scenarios, over half said they would approve the intervention or would advise their children with DS to do so. Responses to hypothetical prenatal and pediatric cognitive interventions were significantly affected by participants’ assessments of the impact of DS on their children’s and their families’ lives, while physical and adult cognitive scenarios were not. Conclusion: Future interventions to address genetic conditions will impact patient communities and cannot succeed without their input and support. While many parents of people with DS indicated approval for hypothetical genetic therapies, these results indicate a need for continuing dialogue about benefits and drawbacks of gene modification technologies.

KW - CRISPR

KW - Down syndrome

KW - Gene editing

KW - Gene silencing

KW - Intellectual disability

UR - http://www.scopus.com/inward/record.url?scp=85048804630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048804630&partnerID=8YFLogxK

U2 - 10.1038/s41436-018-0077-6

DO - 10.1038/s41436-018-0077-6

M3 - Article

C2 - 29930393

AN - SCOPUS:85048804630

SP - 1

EP - 6

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

ER -